|
Originally published In Press as doi:10.1074/jbc.M204759200 on September 7, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47399-47406, December 6, 2002
NHE1 Regulates the Stratum Corneum Permeability Barrier
Homeostasis
MICROENVIRONMENT ACIDIFICATION ASSESSED WITH FLUORESCENCE
LIFETIME IMAGING*
Martin J.
Behne §,
Jamie W.
Meyer¶ ,
Kerry M.
Hanson**,
Nicholas P.
Barry**,
Satoru
Murata ,
Debra
Crumrine ,
Robert W.
Clegg**,
Enrico
Gratton**,
Walter M.
Holleran ,
Peter M.
Elias , and
Theodora M.
Mauro
From the Dermatology Service, Veterans Affairs
Medical Center and Department of Dermatology, University of California,
San Francisco, California 94121, the ¶ Department of Molecular
Genetics, Biochemistry, and Microbiology, University of Cincinnati
College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267, and the ** Laboratory for Fluorescence Dynamics, Department
of Physics, University of Illinois,
Urbana-Champaign, Illinois 61801
Received for publication, May 15, 2002, and in revised form, September 4, 2002
 |
ABSTRACT |
The outermost epidermal layer, the stratum
corneum (SC), exhibits an acidic surface pH, whereas the pH at its base
approaches neutrality. NHE1 is the only
Na+/H+ antiporter isoform in
keratinocytes and epidermis, and has been shown to regulate
intracellular pH. We now demonstrate a novel function for NHE1, as we
find that it also controls acidification of extracellular
"microdomains" in the SC that are essential for activation of
pH-sensitive enzymes and the formation of the epidermal permeability
barrier. NHE1 expression in epidermis is most pronounced in granular
cell layers, and although the surface pH of NHE1 knockout mice is only
slightly more alkaline than normal using conventional pH measurements,
a more sensitive method, fluorescence lifetime imaging, demonstrates
that the acidic intercellular domains at the surface and of the lower
SC disappear in NHE1 / animals. Fluorescence lifetime imaging
studies also reveal that SC acidification does not occur through a
uniform gradient, but through the progressive accumulation of acidic
microdomains. These findings not only visualize the spatial
distribution of the SC pH gradient, but also demonstrate a role for
NHE1 in the generation of acidic extracellular domains of the lower SC,
thus providing the acidification of deep SC interstices necessary for lipid processing and barrier homeostasis.
 |
INTRODUCTION |
Cultured keratinocytes express the sodium-proton exchanger
(NHE)1 class of
non-energy-dependent transporters, which controls
intracellular pH (1). Recently, the NHE1 isoform has been shown to be
the only isoform in keratinocytes and epidermis (2).
Acidification is essential for the epidermal permeability barrier, as
shown by the observation that barrier recovery proceeds normally at an
acidic pH, but is delayed at a neutral pH (i.e. pH 7-7.4)
as a result of impaired post-secretory processing of secreted,
extracellular lipids in the lower SC (3). The delay in recovery at a
neutral pH is explained by the in situ activity profiles of
-glucocerebrosidase ( -Glc-Cer'ase), and acid-sphingomyelinase (aSM'ase) in the SC, which lack activity at a neutral pH (4, 5).
-Glc-Cer'ase and aSM'ase comprise two key lipid hydrolases, which
are critical for the formation of mature extracellular lamellar bilayers (6, 7), and both are required for the normal processing of
secreted polar lipid precursors into their more non-polar species.
The acidic pH of the SC has been attributed largely to mechanisms
extrinsic to the epidermis, such as: (a) byproducts of
microbial metabolism (8); (b) lactic acid and lactate from
sweat (9); (c) free fatty acids (10); (d)
progressive desiccation of the SC (11), and/or (e)
generation of the organic acid, cis-urocanic acid (cUCA) from filaggrin
(12). In this report, we demonstrate that NHE1 deletion or
pharmacologic inhibition elevates SC pH and impedes both lipid
processing and resulting barrier repair, suggesting this agent is
essential in establishing and/or maintaining SC pH.
The aim of this study was to assess the effect of NHE1 on extracellular
acidification of the SC and to visualize the spatial distribution of
the SC pH gradient. Because the origin and character of the acidic pH
of the SC have been difficult to study, we adapted a more sophisticated
method, fluorescence lifetime imaging (FLIM), to investigate SC pH
(13). Using this method, we find that the pH "gradient" is not
uniform, and that NHE1 preferentially acidifies extracellular domains
at and just above the stratum granulosum (SG)-SC junction. Moreover,
NHE1 expression increases in the outer epidermis, in an increasingly
apical pattern, thus providing the acidic milieu necessary for
formation of mature extracellular lipid bilayers in the SC.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Amiloride and HEPES were purchased from Sigma.
2',7'-Bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF) was from
Molecular Probes (Eugene, OR). HOE694 was kindly provided by Dr.
H. J. Lang (Aventis Pharma Deutschland GmbH, Frankfurt am Main,
Germany). All other reagents were of analytical grade.
Animals--
Male hairless mice (SKH1 hr/hr, Charles River
Laboratories, Wilmington, MA) were fed Purina mouse diet and water
ad libitum. Animals were 8-12 weeks old at time of
experiments. Heterozygous, NHE1-deficient mice (14) were bred locally
from heterozygous founders received from Dr. G. E. Shull
(Cincinnati, OH), and each litter was genotyped separately. Mice were
maintained on a mixed background of SVJ129 and Black Swiss, and inbred
for at least 4 generations. Functional experiments were performed on
animals aged 6-10 weeks.
Immunohistochemistry--
Fresh biopsies from NHE1 +/+ or /
mice were formaldehyde-fixed, paraffin-embedded, and sectioned (5 µm). For immunolabeling of NHE1, a rabbit polyclonal antibody was
used (Chemicon International, Temecula, CA), which was detected via a
FITC-labeled, secondary goat anti-rabbit antibody (Cappel, Organon
Teknika Corp., Durham, NC). Sections were counterstained with propidium
iodide (Sigma), and pictures were taken on a Leica TCS-SP confocal microscope.
Fluorescence Lifetime Imaging Microscopy--
pH was determined
using the lifetime-sensitive fluorescent pH indicator BCECF (Molecular
Probes). We have examined the question of possible vehicle toxicity in
previous studies and found that applications of propylene
glycol/ethanol (in a 7:3 mix) do not exhibit deleterious effects on
either permeability barrier function or on the structure of the SC, and
do not alter the kinetics of barrier recovery in acute experiments
(see, e.g., Ref. 15). Moreover, following prolonged ethanol
exposure (twice daily over 7 days), such effects are limited to
superficial layers of the SC, where SC interstices are expanded without
disrupting the lamellar lipid domains. Even under these conditions,
ethanol neither breaches the corneocyte, nor the barrier-forming, lower
two thirds of the SC (16), definitely excluding the nucleated layers of
the epidermis (17), with no effects on base line barrier function (18). In these experiments, the solvent was a 7:3 mix of propylene glycol and
ethanol, used because it produces better SC penetration. Whereas propylene glycol/ethanol elicits the minor effects described above, ethanol alone would be expected to produce even fewer effects because
of rapid surface evaporation. The dye was therefore applied in pure
ethanol (58-120 µM BCECF), four times over the course of
1 h, and reapplied only after remaining ethanol had evaporated. A
biopsy was taken ~15 min following the last dye application, mounted
for microscopy, and directly visualized (maximum time delay 1 h).
Additionally, we examined the possible influence of cholesterol as a
key epidermal lipid, and ethanol as the solvent in our experiments on
lifetime measurements. A saturated solution of cholesterol in buffer
did not affect lifetimes, when corrected for its index of refraction.
Similarly, water/ethanol mixtures with up to 5% ethanol also did not
change lifetime, even without a correction for refraction.
Two-photon FLIM (19-21) was used to determine pH. The specific
protocols used to determine pH as a function of epidermal depth and
cellular location were validated (13). In brief, a Millenia-pumped Tsunami titanium:sapphire laser system (Spectra-Physics) was used as
the two-photon excitation source. Two-photon excitation of the sample
was achieved by coupling the 820-nm output of the laser through the
epifluorescence port of a Zeiss Axiovert microscope. Less than 1 milliwatt was used to excite the sample. The excitation beam was
diverted to the sample by a dichroic filter, and the fluorescence was
collected using a Hamamatsu (R3996) photomultiplier placed at the
bottom port of the microscope. Scanning mirrors and a 40× infinity
corrected oil objective (Zeiss F Fluar, 1.3 numeric aperture) were used
to image areas of 214 µm2. Z-slices (1.7 µm/slice) were
obtained by adjusting the objective focus with a motorized driver (ASI
Multi-Scan 4). Lifetime data were acquired using the frequency-domain
method (80 MHz). Fluorescein was used as the reference lifetime
standard ( f = 4.05 ns, pH 9.5). Data evaluation and
visualization were performed directly with the in-house software
SIM-FCS. Fluorescence intensity images were adjusted to enhance
structural features and to visualize dye distribution and penetration.
Lifetime values were converted to pH values, based on a calibration of
BCECF in a series of buffers of different pH. The resulting pH maps are
displayed on the same color scale to facilitate comparisons. The pH
value distribution within these images is depicted in the corresponding
histograms. Individual images in Fig. 2 were combined using Adobe
Illustrator (Adobe Systems Inc., San Jose, CA), but no further image
processing was performed. Background fluorescence was measured in
samples of unstained tissue, treated otherwise identically. Intensity counts were always below 10/50 µs, even in surface images (or below
5% of the low intensity images in the series presented here) (13).
Permeability Barrier Function--
Transepidermal water loss was
measured with an electrolytic water analyzer (MEECO, Warrington, PA).
Individually tested sites were covered with Hilltop chambers (nominal
volume 200 µl), which were reapplied following each individual
measurement. For topical inhibitor applications, solutions of HEPES
buffer (10 mM) at either pH 7.4 or 5.5, contained either
amiloride (5 µM), HOE694 (7.5 µM), or
buffer alone. The inhibitor-concentrations were chosen in the range of
the published 50% inhibitory concentrations (IC50) for
NHE1 inhibitory compounds in fibroblasts (22, 23).
The SC of hairless mice was removed from two sites by several
sequential strippings with adhesive tape (Tesa, Beiersdorf, Germany),
inducing an increase in transepidermal water loss levels above base
line (from <0.2 to ~7-9 g/m2/h). After stripping,
inhibitors (conditions as above) were applied and transepidermal water
loss was measured at 0, 2, 5, and 24 h. For studies in NHE1
knockout mice, homozygous ( / ) mice were compared with their
wild-type (+/+) littermates, or age-matched wild-type animals of the
same inbreeding generation. Flanks of these mice were shaved, and
barrier homeostasis was studied between 48 and 96 h later. For
tape-stripping of these animals, D-squame disks (Acaderm, Menlo Park,
CA) were used, as Tesa tape was too disruptive for application to
shaved, hairy mouse skin.
Conventional surface pH measurements were performed using a flat glass
surface electrode (Mettler-Toledo, Giessen, Germany) with a pH
meter (Skin pH Meter PH 900; Courage & Khazaka, Cologne, Germany).
Ultrastructural Methods--
Freshly obtained biopsies from
mouse skin (inhibitor and buffer-treated hairless mice 5 h
following tape-stripping; NHE1 / and +/+ mice 8 h following
tape-stripping, the time points that corresponded to the maximum delay
in barrier recovery), were fixed directly in modified Karnovsky's
fixative, postfixed with reduced osmium tetroxide (OsO4),
and then embedded in an Epon-epoxy mixture. For visualization of
lipid-enriched, lamellar bilayer structures, some samples were
postfixed with ruthenium tetroxide (RuO4). Sections were
cut on a Reichert Ultracut E microtome, counterstained with uranyl
acetate and lead citrate, and viewed in a Zeiss 10 CR electron microscope, operated at 60 kV.
 |
RESULTS |
The Epidermal Localization of NHE1 Is Consistent with Its Putative
Role in SC Acidification--
We first assessed the localization of
NHE1 in murine epidermis by immunohistochemistry. As seen in Fig.
1A, NHE1 is present in all
epidermal cell layers. Its expression increases in the epidermal outer
nucleated cell layers, especially in the apical surface of cells, and
disappears in the enucleated cells above the SG-SC interface. Omission
of the primary antibody eliminates virtually all epidermal staining
(not shown). Immunostaining also is absent in NHE1 knockout ( / )
versus wild-type (+/+) epidermis (Fig. 1, B
versus A), demonstrating the specificity of this
labeling. These images demonstrate that NHE1 is expressed more
abundantly in a suprabasal and apical pattern, consistent with a novel
role in extracellular acidification of the SC.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Epidermal expression of NHE1. Sections
were stained using a polyclonal anti-NHE1 antibody, detected
with a FITC-labeled secondary antibody, counterstained with propidium
iodide, and visualized on a Leica Confocal TCS SP microscope. The
images represent the superposition of the green FITC label (NHE1) with
the red propidium iodide label (DNA). Magnification bar
represents 10 µm. A, NHE1 +/+ mice display increasing
expression of NHE1 in more differentiated layers of the epidermis.
B, to ensure the specificity of this staining pattern, we
performed the same staining on NHE1 / mouse skin. NHE1 staining was
equal to background intensity under identical conditions.
|
|
Deletion of NHE1 Results in Reduced Acidification at the SG-SC
Interface--
Traditional skin surface pH measurements do not reveal
detailed information about pH changes deep within the SC, or within specific microdomains (e.g. in the corneocyte interstices).
Moreover, tape-stripping to measure pH in deeper levels of the SC, the
only method available until now, inevitably disturbs the tissue pH equilibrium. We therefore employed FLIM as a novel method to visualize pH in intact, unperturbed SC (13) and as a function of depth within the
outer epidermis of NHE1 knockout mice (Fig.
2B) versus their
wild-type littermates (Fig. 2A). FLIM
measurements are dye concentration-independent, are not prone to
photobleaching, and offer a look deep into intact tissue (19, 21). This
method therefore reveals differential pH changes with great detail,
here displayed as pH maps of the SC (13, 20). Because both surface pH
and the slope of SC pH are important in epidermal barrier homeostasis (11), we measured pH at different levels of the SC. The increased spatial resolution of FLIM distinguishes differences in the pH of SC
extracellular versus intracellular domains, as well as
depth-dependent pH changes, conventionally referred to as
the pH gradient (24). BCECF, the pH-sensitive indicator in these
experiments, is used normally as an acetoxymethyl ester for
intracellular measurements, because this uncharged molecule (but not
the free acid BCECF) can permeate cell membranes (product information,
Molecular Probes, Eugene, OR). Nevertheless, living cells do not
exclude BCECF free acid completely (25). Using FLIM, we were able to
measure the relative amounts of BCECF in the intracellular
versus extracellular compartments, and found that BCECF free
acid penetrates into cells (the ratio of intracellular to extracellular
dye concentration in the SC is ~1:10), which we attribute to the
nature of the SC, i.e. the enucleated corneocytes of this
non-viable layer become more permeable and cannot exclude the dye
effectively. Additionally, because of the increased sensitivity of
FLIM, we also were able to detect BCECF in viable SG cells, albeit in
much lower concentrations than seen in SC corneocytes.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 2.
Fluorescence lifetime imaging of NHE1
wild-type and knockout epidermis. Skin of hairy, shaved mice was
incubated with BCECF, then prepared and visualized as described under
"Experimental Procedures." A, fluorescence lifetime
Images of NHE1 +/+ mice. A series of four consecutive, non-overlapping
images/optical sections, en face view extending
from the SC surface (0 µm) to the SC-SG interface (approximately 6 µm into the epidermis) of untreated mouse
skin. Fluorescence intensity images (left), compared with
fluorescence lifetime, which was converted to pH maps
(middle column), and a histogram of this pH
distribution (right); pH color scale at top.
B, FLIM images for NHE1 / mice, presented in the same
fashion as in A. Note the lesser variation of pH values in
the pH maps, and unchanging pH profile in the histograms. C,
pH changes as a function of tissue depth within intact epidermis of
both NHE1 +/+ (A) and / mice (B).
Three-dimensional combination of the individual pH histograms shown in
A and B (right columns).
The decreasing acidity over the first 0-6 µm depicts the SC pH
gradient, and remaining acidity in deeper SC layers of NHE1 +/+ mice
reveals the previously unknown acidic microdomains. In contrast, the
almost complete absence of acidity throughout the SC of NHE1 / mice
reveals the importance of NHE1 for SC acidification.
|
|
In wild-type SC, FLIM reveals acidic (~ pH 6) and neutral (~ pH
6.8) areas (compare histograms in Fig. 2A), and the
section-individual pH histograms show a change from predominantly
acidic to a predominantly neutral pH from the upper to the lower SC
(from outward to inward optical sections). Nevertheless, even at a
depth that represents the SG-SC interface (6-8 µm), acidity is still
present in extracellular microdomains, ensuring an optimal pH for
enzymes such as -Glc-Cer'ase and aSM'ase (6, 7), which are
required for extracellular lipid processing. Because the outline of
corneocytes can be seen clearly in the intensity images, intra- and
extracellular values are identified through side-by-side comparison of
intensity images (left column) and FLIM/pH maps
(center column), which allows identification and
localization of acidic microdomains to extracellular areas of the SC.
Although the acidity of each microdomain is constant, the number of
acidic microdomains increases in more superficial layers of the SC. The
overall change in pH therefore lies in the number of acidic
versus neutral areas (or in the number of acidic versus neutral pixels). In NHE1 / mice, the acidic
signal is almost completely absent from extracellular membrane domains
(Fig. 2B) in the SC. In essence, the extracellular
acidification is blunted in NHE1 / SC (Fig. 2, A and
B). Using three-dimensional histograms, we find that the
acidic spike that corresponds to extracellular acidification starts in
the lower SC and increases steadily in the NHE1 +/+ mice. In contrast,
this acidic spike is missing completely in the NHE1 /
mice (Fig. 2C). The individual FLIM images (Fig. 2,
A and B, center column) and
the histograms derived from them (Fig. 2, A and
B, right column) both demonstrate that
the NHE1 is responsible for acidification of extracellular microdomains
in SC.
To compare NHE1 wild-type and knockout animals further, three
independent FLIM experiments per genotype were performed, and the pH of
sections for the surface, and of SC/SG level were compared. The
two-sided t test for these values confirms that the surface pH on the knockout and wild-type mice are significantly different (Table I). However, the NHE1
/ pH measurements do not differ when surface and SC/SG
interface pH are compared, consistent with an inability to acidify the
SC in NHE1 / skin to normal levels.
View this table:
[in this window]
[in a new window]
|
Table I
Comparison of SC pH in NHE1 wild type and knockout
To compare pH changes between NHE1 wild-type and knockout animals
statistically, three independent FLIM experiments per genotype were
performed, and the pH of sections for the surface, and of SC/SG level
were compared. The two-sided t test for these values
confirms that the surface pH on the knockout and wild-type mice are
significantly different. However, the NHE1 / pH measurements do not
differ when surface and SC/SG interface pH are compared, consistent
with an inability to acidify the SC in NHE1 / skin to normal
levels.
|
|
When FLIM was compared with standard flat electrode measurements, we
found that many of the changes seen with FLIM were not distinguishable
using the flat electrode, which suffers both from lower sensitivity and
lower spatial resolution. For example, skin surface pH of NHE1 /
animals as measured with the flat electrode was only slightly but
significantly elevated in comparison to their NHE1 +/+ littermates (pH
6.01 versus pH 5.75, p = 0.02, n = 13 and 15, respectively; compare with Fig. 2). The
difference in absolute pH values between FLIM and flat surface pH
electrode may also demonstrate the introduction of another artifact,
the water necessary to wet the glass electrode, which further
reduces the sensitivity of the glass electrode. Because the
abnormalities seen with FLIM correlate with functional abnormalities in
lipid processing and epidermal barrier repair (see below), we conclude that the flat electrode is not adequate to study some physiologically important changes in SC pH.
In summary, comparing epidermal structure via dye distribution with pH
distribution maps, acidic pH localizes predominantly to extracellular
domains of the SC, and acidity is almost completely absent from
extracellular domains of NHE1 / SC.
Permeability Barrier Homeostasis Is Abnormal in Transgenic NHE1
Knockout Mice--
To determine the importance of epidermal
acidification through NHE1, we next examined its function in epidermal
barrier homeostasis of NHE1 / mice. Although the / animals were
somewhat smaller than either their wild-type or heterozygous
littermates at the time of weaning and displayed an ataxic gait as part
of the reported epilepsy (14, 26), the skin of knockout animals
appeared clinically and histologically normal. Transepidermal water
loss as a measure of permeability barrier function in / mice did
not differ from +/+ littermates at base line (data not shown),
demonstrating that the smaller size of affected animals did not cause a
nonspecific epidermal barrier defect. However, differences in barrier
homeostasis between knockout and wild-type animals became apparent
after barrier disruption by sequential removal of the outermost SC
layers by gentle tape-stripping (Fig.
3a). NHE1 / animals had
slower barrier recovery, with significant differences at both 5 and
8 h after tape-stripping ( / animals versus +/+
littermates, p < 0.005, two-tailed t test).
Barrier recovery kinetics of NHE1 / mice was similar to those of
normal, hairless mice treated with the NHE1 inhibitor HOE694 (results
below; c.f. Fig.
4a). These results demonstrate
that the presence or absence of the NHE1 antiporter has important
functional consequences for normal epidermal permeability barrier
homeostasis.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 3.
a, barrier recovery of NHE1 / mice
compared with their +/+ littermates. Paired mice were shaved and
tape-stripped following an interval of at least 48 h. Barrier
recovery was monitored for 30 h. Graphed values represent means of
28 individual measurements; *, p values are
<0.05, two-tailed t test. b, NHE1 /
ultrastructure. Electron micrographs of NHE1 / mouse skin, compared
with wild-type (RuO4 postfixation; magnification
bars represent 0.25 µm). Before tape-stripping
(pre), wild-type skin (A) displays regular
epidermal architecture, lipid secretion, and processing
(arrowheads; RuO4 postfixation). B,
the / mice also show regular SC structure (arrowheads)
and extracellular lipid secretion proceeds regularly. 8 h after
tape-stripping (post), the wild-type (C) shows
regularly processed bilayers within SC extracellular domains, whereas
in the knockout (D) abnormal lipid processing, lacunae of
unprocessed lipid (*), is visible.
|
|

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 4.
a, effect of pH and NHE1 inhibition on
barrier recovery. Hairless mice were tape-stripped to transepidermal
water loss of 7-9 g/m2/h and Hilltop chambers with or
without HOE694 (7.5 µM) in pH 7.4 or 5.5 HEPES buffer (10 mM) were applied. Control areas were covered with Hilltop
chambers containing HEPES buffer (10 mM) of pH 5.5 and 7.4, respectively. Transepidermal water loss was measured at 0, 2, 5, and
24 h following tape-stripping, and the same Hilltop chambers were
reapplied immediately following measurements. Graphed values represent
percentage of recovery from the defect induced by tape-stripping.
Depicted are means of 14 individual measurements for HOE694; *,
p values are <0.05, two-tailed t test.
b, NHE1-inhibitor/pH-dependent ultrastructure.
Electron micrographs of hairless mouse skin biopsies taken at 5 h
following tape-stripping, incubated with HEPES buffer of pH 7.4. (Magnification bars in A and B
represent 0.25 µm; bar represents 0.5 µm in
C.) A, incubation with HEPES buffer of pH 7.4, no
changes in lipid secretion and extracellular processing
(RuO4 postfixation); B, addition of HOE694
(H), intercellular lacunae (*) of unprocessed lipid persist
within the SC (RuO4 postfixation); C, lipid
secretion proceeds normally (arrowheads; OsO4
postfixation).
|
|
NHE1 Inhibition Delays Epidermal Permeability Barrier Recovery in a
pH-dependent Manner--
As a second model to confirm whether
NHE1-mediated SC acidification is linked to barrier function, we
inhibited the NHE1 pharmacologically. We focused on the kinetics of
barrier recovery, again assessed as changes in transepidermal water
loss rates, after acute barrier perturbations by tape-stripping,
followed by exposure to buffers of different pHs with or without added
inhibitors. We compared the effects of amiloride as the prototypical
NHE inhibitor (27, 28) with the highly specific NHE1 inhibitor HOE694
(29) at various doses on permeability barrier homeostasis. When
amiloride was applied after tape-stripping in a concentration range,
based upon its reported IC50 in fibroblasts
(i.e. 5 µM), a significant delay in barrier
recovery occurred at 2 and 5 h, with normalization of recovery by
24 h. Although in cell culture and in short term measurements of
intracellular pH, 1 µM amiloride is fully inhibitory (1),
the extent of barrier recovery at 24 h may be attributable to the
lower specificity for NHE1 (see also the ultrastructural findings
below). When HOE694 was applied to acutely disrupted skin sites at 1.5 µM, a significant delay in barrier recovery rates also
occurred, which was sustained out to 24 h. A 10-fold increase in
HOE694 concentration (to 15 µM) produced a more marked functional abnormality, with only 50% normalization of barrier function at 24 h. The lack of an additional increase in absolute transepidermal water loss levels with the highest concentration tested
(i.e. 15 µM) makes a toxic effect highly
unlikely (signs of toxicity were also absent by ultrastructural
examination; Fig. 4b). Nevertheless, further experiments,
described below (Fig. 4a), utilized HOE694 at an
intermediate concentration (i.e. 7.5 µM).
Finally, to establish that the barrier defect is linked to an
acidification abnormality, we assessed whether co-applications of an
acidic buffer with the inhibitors would normalize barrier recovery.
Co-applications of an acidic buffer with HOE694 overrode the effects of
the inhibitor alone (Fig. 4a), demonstrating that the
abnormalities in permeability barrier homeostasis are caused by
NHE1-inhibitor-induced alterations in SC acidification.
Blockade or Deletion of NHE1 Results in Altered Extracellular Lipid
Processing--
The structural basis for the knockout- and
inhibitor-induced delays in barrier recovery was assessed by electron
microscopy. Because previous studies found that neutralization of the
SC pH gradient impaired epidermal barrier recovery by preventing the processing of secreted lipids (3), whereas the lamellar body delivery
system remained unaltered (30), we surveyed lamellar body formation and
secretion, as well as the post-secretory, extracellular processing of
lipids in NHE1 / , HOE694-, and amiloride-treated animals.
Electron micrographs of NHE1 / epidermis revealed a defect in
lamellar membrane maturation at the time of maximum delay in epidermal
barrier recovery, i.e. 8 h following barrier disruption (Fig. 3b, panel D; compare with
+/+, panel C), but not under basal conditions (Fig. 3b, panels A and B).
Moreover, the morphology of NHE1 / SC resembled that in
HOE694-treated mice at comparable time points after epidermal barrier
disruption (c.f. Fig. 4b, panel
B). In numerous areas of the lower SC, lipid processing was
delayed, assessed both as a persistence of newly secreted lipids, and
the presence of incompletely processed ("immature") lamellar
membrane structures several layers above the SG-SC interface.
Our earlier study demonstrated that exposure to a neutral pH buffer
delayed epidermal barrier recovery through an inhibition of
extracellular processing, rather than through lamellar body formation/secretion (3). Likewise, micrographs of HOE694-treated epidermis revealed undisturbed lamellar body formation and secretion, as well as an absence of any signs of cytotoxicity (Fig. 4b,
panels B and C), comparable to both
skin exposed to pH 5.5 (data not shown) and wild-type epidermis (Fig.
3b, panels A and C).
However, as with exposure to a neutral pH buffer (3), HOE694
applications provoked the appearance of abnormal lamellar membranes,
observed with ruthenium tetroxide after fixation as the persistence of incompletely processed (immature) extracellular lamellar bilayers several layers above the SG-SC interface (Fig. 4b,
panel B). In contrast, controls from both
inhibitor and transgenic experiments demonstrated completely processed
bilayers, already present at the SG-SC interface and within the first
layer of the SC (Fig. 4b, panel A;
Fig. 3b, panels A and C).
Moreover, when HOE694 was co-applied in an acidic buffer, lamellar
membrane maturation was normal. In contrast to HOE694-treated skin,
however, amiloride treatment leads not only to the expected abnormality
in lipid processing, but also to premature lipid secretion, an effect
attributable to blockade of the ENaC channel (31), which was
absent in HOE694 treatment (Fig. 4b, panel
C; amiloride images not shown).
Pharmacologic (HOE694)-induced NHE1 blockade results in morphologic
effects that an acidic solution can override. These delays are
consistent with and equivalent to epidermal barrier recovery of NHE1
/ mice, strongly suggesting that NHE1-mediated acidification influences epidermal barrier homeostasis primarily through its action
on pH-sensitive extracellular lipid processing events.
 |
DISCUSSION |
Role of the NHE1--
We show here that NHE1 not only has a novel
function in acidifying the extracellular lipid domain of the SC, but
also that the SC acidity generated by this mechanism influences
cutaneous permeability barrier homeostasis and lipid processing, as
evidenced by results comparing normal to HOE694-treated and NHE1 +/+
and / mice. Whereas the NHE1 modulates SC pH, it localizes
primarily to the last nucleated layer of the epidermis, the SG, and not to the SC where acidification and barrier function occurs/resides. Moreover, SC pH seemingly becomes progressively more acidic in the
outer SC, furthest from the location of the NHE1, rather than in the
regions contiguous to the active antiporter. This apparent paradox is
resolved when the topography of SC pH is examined using a more
sophisticated method; i.e. fluorescence lifetime imaging microscopy (FLIM). Previous studies demonstrate that initial lipid processing normally occurs in extracellular domains (3), and that it is
this initial lipid processing step, at the SG-SC interface and in the
lower SC, that is disturbed in: 1) neutral buffer-exposed skin, 2) NHE1
/ mice, and 3) normal mice treated with the specific NHE1
inhibitor, HOE694. This view is supported by insights from other
knockout models/diseases, which also reveal the SG-SC interface to be
an area of intense enzymatic lipid processing activity (5-7, 32). Here
we show with FLIM that this compartment is already acidified in normal
skin, contrary to the conventional view of the pH gradient obtained
with flat electrodes, which would predict this compartment to be
neutral. This finding is consistent with the known sites of lipid
processing of -Glc-Cer'ase and aSM'ase (5-7).
Although intracellular pH has been linked to diverse cellular functions
in various tissues, including cell proliferation, transformation, and
differentiation (1, 33, 34), extracellular acidification also occurs in
a regulated manner. The NHE family of Na+/H+
exchangers is ubiquitous, and their role in acid-base balance is best
understood in kidney (33), where concentration-driven influx of
Na+ provides the driving force for the NHE-mediated
extrusion of H+ into the extracellular domain. NHE1 and
NHE3 are responsible for intracellular pH regulation, but also
H+ secretion/HCO
reabsorption along the proximal nephron (33, 35). In osteoclasts, as in
SC, NHE1 is responsible for H+ secretion, which, similar to
SC, occurs in localized microdomains (reviewed in Ref. 36). Thus, the
SC may have adapted the ubiquitous ability of the NHE1 to secrete
H+ to a specialized function, i.e. acidification
of microdomains in the lower SC. In recent years, NHE1 has been shown
to assume unexpected functions, in cell adhesion and spreading through
effects on structural filaments (37). To this list, we now add the
function of regulating epidermal barrier homeostasis through control of SC pH and lipid processing.
Although the NHE1 is present in highest quantities in the terminal
nucleated cell layers of the epidermis (i.e. the SG),
several lines of evidence argue that impairment of lipid processing,
not impairment of keratinocyte differentiation, at the interface
between SG and SC is the primary defect when the NHE1 is disabled.
First, we observed normal appearing keratinocyte differentiation, and normal epidermal and keratinocyte cellular morphology in HOE694-treated and NHE1 / mice, suggesting that cellular function(s) are mostly normal. Second, epidermal barrier repair and lipid processing were
impeded within 2 h of pharmacologic inhibitor treatment, an
interval during which effects on cell growth and differentiation are
minimal. Finally, following tape-stripping, lamellar body formation and
lipid secretion, but not lipid processing, appear normal in NHE1 /
mice. The potential indirect effects of altered intracellular acidity
on these extracellular events remain to be determined.
Generation and Measurement of the SC pH Gradient--
The acid
mantle of the SC is postulated to regulate several key epidermal
functions, including epidermal barrier homeostasis (3, 38, 39),
desquamation (11), and antimicrobial capacity (40, 41). Formation of a
competent epidermal barrier requires two processes: synthesis and
secretion of lipid from SG cells into the lower SC interstices,
followed by processing of the secreted lipid into functionally
competent lamellar membranes. Although secretion is controlled by
extracellular Ca2+ and K+ concentrations (30),
processing is regulated by fluctuations in extracellular pH (3). The
acidic SC appears to control lipid processing and epidermal barrier
homeostasis through two or more pH-dependent, lipid
hydrolases ( -Glc-Cer'ase, aSM'ase), that are essential for the
extracellular processing of SC lipid precursors. These hydrolases,
which generate the complete family of seven epidermis-unique ceramides
from glucosylceramides and sphingomyelin (42), become inactive when SC
is exposed to a neutral pH (3), consistent with their known acidic pH
optimum (5-7).
Traditionally, pH has been assessed in the mammalian SC using a flat pH
electrode, accessing progressively lower layers of the SC by removal of
sequential SC layers with tape-stripping. This flat electrode method,
introduced in 1939 (43), is not only inherently disruptive, but it is
an "averaging method" that can only assess mean pH across a wide
area. Such a method can neither distinguish between intracellular and
extracellular pH, nor identify microdomains of greater or lesser pH in
close proximity within the SC. Using FLIM to measure and simultaneously
visualize pH distribution, we identified previously unknown, acidic
membrane compartments, "microdomains," at the SG-SC interface, and
in the lower SC interstices, revealing significant complexities in the SC pH gradient. Unlike tape-stripping, FLIM does not disrupt the SC to
measure pH in the lower SC layers. Moreover, FLIM measurements eliminate other potential artifacts usually inherent to a fluorescent dye approach, as they do not result in photobleaching and are independent of pH-sensing dye concentration (especially important as
the barrier properties of skin create a dye gradient (Ref. 44)). Still,
the physical dimensions of the two-photon focus, or the point-spread
function of the microscopic system, limit the resolution and
determination of intra- versus extracellular compartments
within the SC. Nevertheless, the extracellular domains as present in
the en-face view that this system generates
should be rather homogeneous, based on the columnar stacking of
corneocytes (45-48), whereas the horizontal inter-corneocyte spaces
are small compared with the corneocyte volume; the error based on the
assignment of specific compartments should therefore be small.
FLIM therefore provides novel insights into the generation and spatial
distribution of acidic microdomains, which may alter the current view
of potential contributors to SC acidity. Previously, a number of
mechanisms have been proposed as sources for the acidic surface of
skin. In general, these sources can be viewed as catabolic processes
within the SC, providing acidic end products. For example, the
breakdown of proteins (and the generation of the organic acid cUCA from
filaggrin (Ref. 12)) or lipids (phospholipid hydrolysis to free fatty
acids (Ref. 10)), either intrinsically through specific enzymes, or as
byproducts of microbial metabolism (8), has received most attention.
Additionally, through skin appendages, acidic material may be deposited
onto the SC surface, e.g. lactic acid and lactate from sweat
(9) and sebum-derived free fatty acids (49).
cUCA generation in SC as a mechanism for acidification, while providing
a compelling mathematical concept (12), to date has not been thoroughly
tested. Further, it cannot explain acidification at the SG-SC interface
but rather complies with the conventional view of an inner-to-outer SC
pH gradient. Additionally, such a mechanism would predict a more acidic
pH within the corneocytes themselves, where cUCA is generated from
abundant filaggrin. Similarly, how free fatty acids as lipophilic
compounds can contribute to acidity in a generally dry environment is
not fully understood. However, several studies indicate that formation
of the ordered extracellular lipid bilayer structures, which include
free fatty acids, requires an acidic pH rather than creating it
(49-51). Further, the phospholipases known to date to be present in SC
and responsible for cleavage of phospholipids (52) exhibit general
characteristics that may indicate a dependence on neutral pH, and
requiring millimolar calcium concentrations (reviewed in Ref. 53).
Therefore, recent results with pharmacologic soluble phospholipase
A2 inhibition demonstrating changes in surface pH (10), but
only a delayed effect on SC lipid composition (54), should be viewed
with caution, especially in light of the unknown specificity of the
soluble phospholipase A2 inhibitors used (55). Microbial
metabolism, sweat, and sebum, although they may be significant
contributors to the very surface of SC, do not readily explain
acidified compartments in deeper SC layers. Finally, these processes
vary greatly as a result of seasonal changes, body type, and age, and
may therefore not be able to provide sufficient acidity at all times
and in an evenly distributed fashion over the whole integument.
In contrast, our experiments provide evidence for an intrinsic,
regulated pathway that can supply protons directly to the SC
compartment, where enzymatic activity requires acidity, and where
proper epidermal function is dependent on it. Furthermore, this effect
appears to be specific for and to the SC, as pH in the SG layer does
not change in NHE1 / mice, where SC acidity is absent.
Nevertheless, any or all of the mechanisms discussed above could
contribute to additional acidification following the initial
NHE1-mediated microdomain acidification at the SG-SC junction.
In summary, the experiments described above demonstrate that NHE1
inactivation alone is sufficient to impede SC acidification, and
specifically to alter pH at a critical domain, i.e. the
SG-SC interface and lower SC. We speculate, therefore, that the NHE1 provides the initial step in establishing the SC acidity required for
lipid processing that leads to a functional permeability barrier in
normal epidermis, whereas other pathways may contribute acidic components in more superficial SC layers.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants AR44341 (to T. M. M.), AR19098 (to P. M. E.), and Department of Veterans Affairs Merit Review MAU 3 "Creation and Maintenance of the Epidermal pH Gradient" (to T. M. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a grant from Sebapharma, Boppard, Germany. To
whom correspondence should be addressed: University of California San
Francisco and Department of Veterans Affairs Medical Center, Dermatology Service (190), 4150 Clement St., San Francisco, CA 94121. E-mail: behnemj@itsa.ucsf.edu.
Supported in part by funds from National Institutes of Health
Grant HL61974 (to Gary Shull).
Published, JBC Papers in Press, September 7, 2002, DOI 10.1074/jbc.M204759200
 |
ABBREVIATIONS |
The abbreviations used are:
NHE, sodium-proton
exchanger;
-Glc-Cer'ase, -glucocerebrosidase;
aSM'ase, acid-sphingomyelinase;
cUCA, cis-urocanic acid;
FLIM, fluorescence
lifetime imaging;
SC, stratum corneum;
SG, stratum granulosum;
BCECF, 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein;
FITC, fluorescein
isothiocyanate.
 |
REFERENCES |
| 1.
|
Mauro, T.,
Dixon, D. B.,
Hanley, K.,
Isseroff, R. R.,
and Pappone, P. A.
(1995)
J. Invest. Dermatol.
105,
203-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Sarangarajan, R.,
Shumaker, H.,
Soleimani, M., Le,
Poole, C.,
and Boissy, R. E.
(2001)
Biochim. Biophys. Acta
1511,
181-192[Medline]
[Order article via Infotrieve]
|
| 3.
|
Mauro, T.,
Holleran, W. M.,
Grayson, S.,
Gao, W. N.,
Man, M. Q.,
Kriehuber, E.,
Behne, M.,
Feingold, K. R.,
and Elias, P. M.
(1998)
Arch. Dermatol. Res.
290,
215-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Holleran, W. M.,
Takagi, Y.,
Imokawa, G.,
Jackson, S.,
Lee, J. M.,
and Elias, P. M.
(1992)
J. Lipid Res.
33,
1201-1209[Abstract]
|
| 5.
|
Takagi, Y.,
Kriehuber, E.,
Imokawa, G.,
Elias, P. M.,
and Holleran, W. M.
(1999)
J. Lipid Res.
40,
861-869[Abstract/Free Full Text]
|
| 6.
|
Schmuth, M.,
Man, M. Q.,
Weber, F.,
Gao, W.,
Feingold, K. R.,
Fritsch, P.,
Elias, P. M.,
and Holleran, W. M.
(2000)
J. Invest. Dermatol.
115,
459-466[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Jensen, J. M.,
Schutze, S.,
Forl, M.,
Kronke, M.,
and Proksch, E.
(1999)
J. Clin. Invest.
104,
1761-1770[Medline]
[Order article via Infotrieve]
|
| 8.
|
Korting, H. C.,
Kober, M.,
Mueller, M.,
and Braun-Falco, O.
(1987)
Acta Derm. Venereol.
67,
41-47[Medline]
[Order article via Infotrieve]
|
| 9.
|
Patterson, M. J.,
Galloway, S. D.,
and Nimmo, M. A.
(2000)
Exp. Physiol.
85,
869-875[Abstract]
|
| 10.
|
Fluhr, J. W.,
Kao, J.,
Jain, M.,
Ahn, S. K.,
Feingold, K. R.,
and Elias, P. M.
(2001)
J. Invest. Dermatol.
117,
44-51[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Ohman, H.,
and Vahlquist, A.
(1998)
J. Invest. Dermatol.
111,
674-677[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Krien, P. M.,
and Kermici, M.
(2000)
J. Invest. Dermatol.
115,
414-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hanson, K. M.,
Behne, M. J.,
Barry, N. P.,
Mauro, T. M.,
Gratton, E.,
and Clegg, R. M.
(2002)
Biophys. J.
83,
1682-1690[Medline]
[Order article via Infotrieve]
|
| 14.
|
Bell, S. M.,
Schreiner, C. M.,
Schultheis, P. J.,
Miller, M. L.,
Evans, R. L.,
Vorhees, C. V.,
Shull, G. E.,
and Scott, W. J.
(1999)
Am. J. Physiol.
276,
C788-C795[Medline]
[Order article via Infotrieve]
|
| 15.
|
Man, M. Q.,
Feingold, K. R.,
and Elias, P. M.
(1993)
Arch. Dermatol.
129,
728-738[Abstract/Free Full Text]
|
| 16.
|
Menon, G. K.,
and Elias, P. M.
(1997)
Skin Pharmacol.
10,
235-246[Medline]
[Order article via Infotrieve]
|
| 17.
|
Komuves, L. G.,
Hanley, K.,
Man, M. Q.,
Elias, P. M.,
Williams, M. L.,
and Feingold, K. R.
(2000)
J. Invest. Dermatol.
115,
361-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Menon, G. K.,
Feingold, K. R.,
Mao-Qiang, M.,
Schaude, M.,
and Elias, P. M.
(1992)
J. Invest. Dermatol.
98,
209-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Masters, B. R., So, P. T.,
and Gratton, E.
(1997)
Biophys. J.
72,
2405-2412[Medline]
[Order article via Infotrieve]
|
| 20.
|
Szmacinski, H.,
and Lakowicz, J. R.
(1993)
Anal. Chem.
65,
1668-1674[Medline]
[Order article via Infotrieve]
|
| 21.
|
Tadrous, P. J.
(2000)
J. Pathol.
191,
229-234[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Noel, J.,
and Pouyssegur, J.
(1995)
Am. J. Physiol.
268,
C283-C296[Medline]
[Order article via Infotrieve]
|
| 23.
|
Counillon, L.,
Scholz, W.,
Lang, H. J.,
and Pouyssegur, J.
(1993)
Mol. Pharmacol.
44,
1041-1045[Abstract]
|
| 24.
|
Ohman, H.,
and Vahlquist, A.
(1994)
Acta Derm. Venereol.
74,
375-379[Medline]
[Order article via Infotrieve]
|
| 25.
|
Sit, K. H.,
Bay, B. H.,
and Wong, K. P.
(1993)
Anat. Rec.
235,
183-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Bonnet, U.,
Bingmann, D.,
and Wiemann, M.
(2000)
Eur. Neuropsychopharmacol.
10,
97-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Vigne, P.,
Frelin, C.,
Cragoe, E. J., Jr.,
and Lazdunski, M.
(1984)
Mol. Pharmacol.
25,
131-136[Abstract]
|
| 28.
|
Frelin, C.,
Vigne, P.,
Barbry, P.,
and Lazdunski, M.
(1987)
Kidney Int.
32,
785-793[Medline]
[Order article via Infotrieve]
|
| 29.
|
Loh, S. H.,
Sun, B.,
and Vaughan-Jones, R. D.
(1996)
Br. J. Pharmacol.
118,
1905-1912[Medline]
[Order article via Infotrieve]
|
| 30.
|
Lee, S. H.,
Elias, P. M.,
Feingold, K. R.,
and Mauro, T.
(1994)
J. Invest. Dermatol.
102,
976-979[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Mauro, T.,
Guitard, M.,
Behne, M.,
Oda, Y.,
Crumrine, D.,
Komuves, L.,
Rassner, U.,
Elias, P. M.,
and Hummler, E.
(2002)
J. Invest. Dermatol.
118,
589-594[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Holleran, W. M.,
Takagi, Y.,
Menon, G. K.,
Legler, G.,
Feingold, K. R.,
and Elias, P. M.
(1993)
J. Clin. Invest.
91,
1656-1664[Medline]
[Order article via Infotrieve]
|
| 33.
|
Capasso, G.,
Saviano, C.,
Rizzo, M.,
Pica, A.,
Capodicasa, D.,
Mascolo, N.,
and De Santo, N. G.
(1997)
Miner. Electrolyte Metab.
23,
243-248[Medline]
[Order article via Infotrieve]
|
| 34.
|
Reshkin, S. J.,
Bellizzi, A.,
Caldeira, S.,
Albarani, V.,
Malanchi, I.,
Poignee, M.,
Alunni-Fabbroni, M.,
Casavola, V.,
and Tommasino, M.
(2000)
FASEB J.
14,
2185-2197[Abstract/Free Full Text]
|
| 35.
|
Pannabecker, T. L.,
Brokl, O. H.,
Kim, Y. K.,
Abbott, D. E.,
and Dantzler, W. H.
(2002)
Pflugers Arch.
443,
446-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Rousselle, A. V.,
and Heymann, D.
(2002)
Bone
30,
533-540[Medline]
[Order article via Infotrieve]
|
| 37.
|
Tominaga, T.,
and Barber, D. L.
(1998)
Mol. Biol. Cell
9,
2287-2303[Abstract/Free Full Text]
|
| 38.
|
Thune, P.,
Nilsen, T.,
Hanstad, I. K.,
Gustavsen, T.,
and Lovig Dahl, H.
(1988)
Acta Derm. Venereol.
68,
277-283[Medline]
[Order article via Infotrieve]
|
| 39.
|
Berg, R. W.,
Milligan, M. C.,
and Sarbaugh, F. C.
(1994)
Pediatr. Dermatol.
11,
18-20[Medline]
[Order article via Infotrieve]
|
| 40.
|
Aly, R.,
Shirley, C.,
Cunico, B.,
and Maibach, H. I.
(1978)
J. Invest. Dermatol.
71,
378-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Korting, H. C.,
Hubner, K.,
Greiner, K.,
Hamm, G.,
and Braun-Falco, O.
(1990)
Acta Derm. Venereol.
70,
429-431[Medline]
[Order article via Infotrieve]
|
| 42.
|
Uchida, Y.,
Behne, M.,
Quiec, D.,
Elias, P. M.,
and Holleran, W. M.
(2001)
J. Invest. Dermatol.
117,
1307-1313[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Blank, I. H.
(1939)
J. Invest. Dermatol.
2,
67
|
| 44.
|
Turner, N. G.,
Cullander, C.,
and Guy, R. H.
(1998)
J. Invest. Dermatol. Symp. Proc.
3,
110-113
|
| 45.
|
Wepf, R.,
Richter, T.,
Koenig, K.,
Dunckelmann, K.,
Sattler, M.,
Biel, S.,
Hintze, U.,
and Wittern, K. P.
(2002)
J. Invest. Dermatol.
119,
250 (Abstr. 256)
|
| 46.
|
Mackenzie, I. C.,
Zimmerman, K.,
and Peterson, L.
(1981)
J. Invest. Dermatol.
76,
459-461[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Mackenzie, J. C.
(1969)
Nature
222,
881-882[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Christophers, E.
(1971)
J. Invest. Dermatol.
56,
165-169[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Lieckfeldt, R.,
Villalain, J.,
Gomez-Fernandez, J. C.,
and Lee, G.
(1995)
Pharm. Res. (N. Y.)
12,
1614-1617
|
| 50.
|
Bouwstra, J. A.,
Gooris, G. S.,
Dubbelaar, F. E.,
Weerheim, A. M.,
and Ponec, M.
(1998)
J. Invest. Dermatol. Symp. Proc.
3,
69-74
|
| 51.
|
Bouwstra, J. A.,
Gooris, G. S.,
Dubbelaar, F. E.,
and Ponec, M.
(2000)
Cell. Mol. Biol.
46,
979-992[Medline]
[Order article via Infotrieve]
|
| 52.
|
Schadow, A.,
Scholz-Pedretti, K.,
Lambeau, G.,
Gelb, M. H.,
Furstenberger, G.,
Pfeilschifter, J.,
and Kaszkin, M.
(2001)
J. Invest. Dermatol.
116,
31-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Six, D. A.,
and Dennis, E. A.
(2000)
Biochim. Biophys. Acta
1488,
1-19[Medline]
[Order article via Infotrieve]
|
| 54.
|
Mao-Qiang, M.,
Jain, M.,
Feingold, K. R.,
and Elias, P. M.
(1996)
J. Invest. Dermatol.
106,
57-63[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Ogata, Y.,
Sakurai, T.,
Nakao, S.,
Kuboyama, N.,
Moriwaki, K.,
Furuyama, S.,
and Sugiya, H.
(2002)
Comp. Biochem. Physiol. C Toxicol. Pharmacol.
131,
315-322[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R.-P. Charles, M. Guitard, C. Leyvraz, B. Breiden, M. Haftek, Z. Haftek-Terreau, J.-C. Stehle, K. Sandhoff, and E. Hummler
Postnatal Requirement of the Epithelial Sodium Channel for Maintenance of Epidermal Barrier Function
J. Biol. Chem.,
February 1, 2008;
283(5):
2622 - 2630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yosipovitch, M. I. Duque, T. S. Patel, Y. Ishiuji, D. A. Guzman-Sanchez, A. G. Dawn, B. I. Freedman, Y. H. Chan, D. Crumrine, and P. M. Elias
Skin barrier structure and function and their relationship to pruritus in end-stage renal disease
Nephrol. Dial. Transplant.,
November 1, 2007;
22(11):
3268 - 3272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ilic, M. Mao-Qiang, D. Crumrine, G. Dolganov, N. Larocque, P. Xu, M. Demerjian, B. E. Brown, S.-T. Lim, V. Ossovskaya, et al.
Focal Adhesion Kinase Controls pH-Dependent Epidermal Barrier Homeostasis by Regulating Actin-Directed Na+/H+ Exchanger 1 Plasma Membrane Localization
Am. J. Pathol.,
June 1, 2007;
170(6):
2055 - 2067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Graham, I. Gatherar, I. Haslam, M. Glanville, and N. L. Simmons
Expression and localization of monocarboxylate transporters and sodium/proton exchangers in bovine rumen epithelium
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R997 - R1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Piwnica, I. Fernandez, N. Binart, P. Touraine, P. A. Kelly, and V. Goffin
A New Mechanism for Prolactin Processing into 16K PRL by Secreted Cathepsin D
Mol. Endocrinol.,
December 1, 2006;
20(12):
3263 - 3278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Houben, W. M. Holleran, T. Yaginuma, C. Mao, L. M. Obeid, V. Rogiers, Y. Takagi, P. M. Elias, and Y. Uchida
Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis
J. Lipid Res.,
May 1, 2006;
47(5):
1063 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|